The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery.
作者信息
Liu Junli, Tsilingiris Dimitrios, Dalamaga Maria
机构信息
Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University Affiliated 6th People's Hospital, Shanghai Diabetes Institute, Shanghai, China.
First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 17 St Thomas Street, 11527, Athens, Greece.
出版信息
Metabol Open. 2022 Jan 19;13:100164. doi: 10.1016/j.metop.2022.100164. eCollection 2022 Mar.
Abstract
摘要
相似文献
1
The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery.肌肉量与身体质量指数（BMI）之间的非线性关系，让人质疑将BMI作为肥胖症手术资格的主要标准的做法。
Metabol Open. 2022 Jan 19;13:100164. doi: 10.1016/j.metop.2022.100164. eCollection 2022 Mar.
2
Pitfalls in using BMI as a selection criterion for bariatric surgery.使用 BMI 作为肥胖症手术选择标准的陷阱。
Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):347-51. doi: 10.1097/MED.0b013e328357f0b8.
3
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益：一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
4
ABSI (A Body Shape Index) and ARI (Anthropometric Risk Indicator) in Bariatric Surgery. First Application on a Bariatric Cohort and Possible Clinical Use.ABSI（身体形态指数）和 ARI（人体测量风险指标）在减重手术中的应用。在减重队列中的首次应用及可能的临床应用。
Obes Surg. 2018 Jul;28(7):1966-1973. doi: 10.1007/s11695-018-3117-z.
5
Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.糖尿病合并病态肥胖患者的减肥手术：一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(22):1-23. Epub 2009 Oct 1.
6
Bariatric surgery in 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year.1119例术前体重指数<35（kg/m²）患者的减肥手术：1年结果
Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1127-32. doi: 10.1016/j.soard.2015.03.012. Epub 2015 Mar 27.
7
Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011-13 Australian Health Survey.澳大利亚可能符合减肥手术条件人群的估计数量及特征：来自2011 - 2013年澳大利亚健康调查的结果
Aust Health Rev. 2018 Aug;42(4):429-437. doi: 10.1071/AH16255.
8
Dual-mobility or Constrained Liners Are More Effective Than Preoperative Bariatric Surgery in Prevention of THA Dislocation.双动型或限制性内衬在预防全髋关节置换术脱位方面比术前减肥手术更有效。
Clin Orthop Relat Res. 2016 Oct;474(10):2202-10. doi: 10.1007/s11999-016-4859-3.
9
Risk Reduction Compared with Access to Care: Quantifying the Trade-Off of Enforcing a Body Mass Index Eligibility Criterion for Joint Replacement.与获得医疗服务相比，风险降低：量化实施关节置换 BMI 资格标准的权衡取舍。
J Bone Joint Surg Am. 2018 Apr 4;100(7):539-545. doi: 10.2106/JBJS.17.00120.
10
Fat mass, but not fat-free mass, predicts increased foot pain with obesity, independent of bariatric surgery.肥胖患者的脂肪质量而非去脂体重与肥胖相关的足部疼痛增加有关，与减重手术无关。
Surg Obes Relat Dis. 2018 Sep;14(9):1389-1395. doi: 10.1016/j.soard.2018.06.015. Epub 2018 Jun 25.
引用本文的文献
1
Prevalence and severity of sarcopenia in patients on maintenance hemodialysis: a cross-sectional study.维持性血液透析患者肌少症的患病率和严重程度：一项横断面研究。
BMC Nephrol. 2024 Oct 29;25(1):385. doi: 10.1186/s12882-024-03836-z.
2
The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies.内分泌干扰物双酚 A 和邻苯二甲酸酯在肥胖中的作用：当前的证据、观点和争议。
Int J Mol Sci. 2024 Jan 4;25(1):675. doi: 10.3390/ijms25010675.
3
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.肥胖与白血病：生物学机制、观点及挑战
Curr Obes Rep. 2024 Mar;13(1):1-34. doi: 10.1007/s13679-023-00542-z. Epub 2023 Dec 30.
4
The association of body mass index and body composition with plasma amyloid beta levels.体重指数和身体成分与血浆β淀粉样蛋白水平的关联。
Brain Commun. 2023 Oct 9;5(5):fcad263. doi: 10.1093/braincomms/fcad263. eCollection 2023.
5
Obesity and Peripheral Artery Disease: Current Evidence and Controversies.肥胖与外周动脉疾病：当前证据与争议。
Curr Obes Rep. 2023 Sep;12(3):264-279. doi: 10.1007/s13679-023-00510-7. Epub 2023 May 27.
6
The : Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity.替尔泊肽，一种用于治疗2型糖尿病和肥胖症的双肠促胰岛素类似物。
Metabol Open. 2022 Dec 5;16:100220. doi: 10.1016/j.metop.2022.100220. eCollection 2022 Dec.
7
Longitudinal analyses of serum neurofilament light and associations with obesity indices and bioelectrical impedance parameters.血清神经丝轻链的纵向分析及其与肥胖指数和生物电阻抗参数的关联。
Sci Rep. 2022 Sep 23;12(1):15863. doi: 10.1038/s41598-022-20398-y.
8
Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges.2019冠状病毒病大流行时代血液系统恶性肿瘤的管理：发病机制、肥胖的影响、前景与挑战
Cancers (Basel). 2022 May 19;14(10):2494. doi: 10.3390/cancers14102494.
本文引用的文献
1
The Nonlinear Relationship Between Psoas Cross-sectional Area and BMI: A New Observation and Its Insights Into Diabetes Remission After Roux-en-Y Gastric Bypass.腰大肌横截面积与 BMI 之间的非线性关系：新观察及其对 Roux-en-Y 胃旁路手术后糖尿病缓解的启示。
Diabetes Care. 2021 Dec;44(12):2783-2786. doi: 10.2337/dc20-2907. Epub 2021 Oct 13.
2
Prediabetes screening: Questionable benefits in the golden years.糖尿病前期筛查：在老年时期益处存疑。
Metabol Open. 2021 Apr 7;10:100091. doi: 10.1016/j.metop.2021.100091. eCollection 2021 Jun.
3
Diabetes mellitus in the era of climate change.气候变化时代的糖尿病
Diabetes Metab. 2021 Jul;47(4):101205. doi: 10.1016/j.diabet.2020.10.003. Epub 2020 Oct 27.
4
Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.胃旁路术与袖状胃切除术治疗糖尿病的 5 年结局比较：全国以患者为中心的临床研究网络（PCORNet）减重研究。
JAMA Surg. 2020 May 1;155(5):e200087. doi: 10.1001/jamasurg.2020.0087. Epub 2020 May 20.
5
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives.肌肉减少性肥胖：流行病学证据、病理生理学和治疗观点。
Curr Obes Rep. 2019 Dec;8(4):458-471. doi: 10.1007/s13679-019-00359-9.
6
Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study.男性的预测瘦体重、脂肪量以及全因和死因特异性死亡率：前瞻性美国队列研究。
BMJ. 2018 Jul 3;362:k2575. doi: 10.1136/bmj.k2575.
7
Fat-Free Mass and Skeletal Muscle Mass Five Years After Bariatric Surgery.减重手术后 5 年的无脂肪质量和骨骼肌质量。
Obesity (Silver Spring). 2018 Jul;26(7):1130-1136. doi: 10.1002/oby.22190. Epub 2018 May 30.
8
Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.体重指数低于35kg/m²的2型糖尿病患者的减重/代谢手术治疗
Diabetes Care. 2016 Jun;39(6):924-33. doi: 10.2337/dc16-0350.
9
Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-Analysis.体重指数（BMI）<30kg/m²的2型糖尿病患者的减肥手术：一项系统评价和荟萃分析
PLoS One. 2015 Jul 13;10(7):e0132335. doi: 10.1371/journal.pone.0132335. eCollection 2015.
10
Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis.减肥手术后2型糖尿病缓解的预测因素：一项荟萃分析。
Obes Surg. 2015 Feb;25(2):199-208. doi: 10.1007/s11695-014-1391-y.
Zotero 插件